Articles tagged with Virus Testing
Researchers investigate DNA repair capacity and its association with melanoma risk, while also exploring the predictive value of HPV testing in managing equivocal Pap tests. Additionally, a study on breast cancer biomarkers finds that measuring uPA and PAI-1 levels may help predict disease course and inform treatment strategies.
Researchers developed a fast laboratory test to study and design new compounds blocking HIV molecular components before infection. The test accelerates the discovery process, allowing pharmaceutical companies to target the entire preintegration complex, a critical step in HIV replication.
Researchers found that prion diseases adapt slowly to new species through a prolonged process, making early detection difficult. The study also showed that the disease can spread rapidly in new hosts under specific conditions.
A study published in JAMA found that the misdiagnosis rate for appendicitis remained high despite the availability of new diagnostic tests, particularly among young women and older men. The researchers analyzed data from 85,790 appendectomies performed in Washington state between 1987 and 1998 and found that the rate of misdiagnosis in...
Researchers at the University of Illinois Chicago have discovered a new way to identify prions, the causative agents of mad-cow and Creutzfeldt-Jakob diseases. The study used yeast to pinpoint unidentified prions, which may be related to the sudden appearance of CJD in older adults.
A retrospective study of 681 HIV-positive patients found that Virco's VirtualPhenotype? and Antivirogram? resistance tests accurately predicted treatment outcomes. Patients receiving three or four active drugs experienced significant reductions in viral load and increases in CD4 cell counts.
A new test combining a vinegar solution with an HPV test accurately detects precancerous lesions and reduces false positives among African women, potentially saving thousands of lives. The test could be easily administered at home or in clinics, making it a game-changer for cervical cancer screening in developing countries.
The study found that 27.2% of HIV patients were resistant to all three classes of drugs, while 29.1% had resistance to two classes and 21.9% were resistant to one. This underscores the importance of resistance testing for treatment decision-making in HIV clinical practice.
The international panel established recommendations for drug resistance testing in treating HIV failure and pregnant women. This guidance aims to optimize the use of these tests in designing effective drug therapies.
A large-scale study found no clear evidence that name-based HIV reporting improves public health outcomes or increases timely medical care. Despite controversy, advocates argue the system helps notify partners and access healthcare, while opponents fear it deters testing.
The American Red Cross has developed a new genetic test, nucleic acid testing (NAT), to detect viruses such as HIV and Hepatitis C Virus (HCV) in blood donations. This technology can identify infectious agents earlier than current screening tests, reducing the risk of disease transmission through blood products.
A Johns Hopkins Medicine program offered HIV testing to emergency department patients, identifying nearly 6.4% of those tested as positive. The study found that voluntary screening improved early detection rates, particularly among high-risk groups such as males and blacks, who had higher rates of HIV positivity.
Researchers have developed a new strategy to determine the early stages of HIV infection, allowing for targeted treatment and study. The approach uses a modified enzyme immunoassay test to distinguish between recent and long-term infections, enabling more precise diagnosis and monitoring of disease spread.
A study published in the Journal of the American Medical Association found that certain symptoms like fever, joint pain, and night sweats can identify people with recent HIV infection before a positive blood test. The researchers screened over 3,800 patients and found that those with these symptoms were more likely to have the virus.
A combination of urine and blood-based tests has been found to be more sensitive in detecting HIV-1 antibodies, potentially identifying individuals with compartmentalized infections or immune responses. This breakthrough could lead to the development of a safe and effective AIDS vaccine.
Research found that 2-3% of pregnant women acquire herpes during pregnancy, with the greatest risk to infants when acquired late. Routine testing for herpes can help prevent transmission and inform birthing decisions.
Researchers found that HIV-positive patients living in the eastern United States are at a higher risk of developing tuberculosis, particularly if they have low levels of CD4 cells. The study also revealed that nearly 25% of those diagnosed with TB died from the disease.
Researchers have developed a rapid virus detection technology for drinking water, recreational waters, and groundwater. The test detects the presence or absence of viruses using a specific enzyme released from cells, providing a more accurate indicator of human health risk.